Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Aytu Biopharma, Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −2 vs. Q1 2022
- Shares held
- 3.62M
- −1.91M (−34.5%) vs. Q1 2022
- Total value
- $2.50M
- −$3.47M (−58.1%) vs. Q1 2022
- New holders
- 7
- 9 more added
- Sold out
- 9
- 8 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 38 | $8.25M |
| Q1 2026 | 37 | $10.7M |
| Q4 2025 | 39 | $9.81M |
| Q3 2025 | 33 | $6.73M |
| Q2 2025 | 32 | $7.45M |
| Q1 2025 | 31 | $2.49M |
| Q4 2024 | 29 | $3.19M |
| Q3 2024 | 24 | $4.81M |
| Q2 2024 | 27 | $5.99M |
| Q1 2024 | 27 | $5.46M |
| Q4 2023 | 22 | $5.02M |
| Q3 2023 | 22 | $4.65M |
| Q2 2023 | 21 | $2.73M |
| Q1 2023 | 21 | $1.21M |
| Q4 2022 | 42 | $1.52M |
| Q3 2022 | 53 | $1.64M |
| Q2 2022 | 41 | $2.50M |
| Q1 2022 | 44 | $6.02M |
| Q4 2021 | 46 | $5.10M |
| Q3 2021 | 49 | $12.2M |
| Q2 2021 | 61 | $26.0M |
| Q1 2021 | 72 | $48.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,090,778 | $753.0K | 0.00% | +368,215+51.0% | Added |
| Renaissance Technologies LLC | 1,055,782 | $728.0K | 0.00% | +290,313+37.9% | Added |
| BlackRock Inc. | 482,611 | $333.0K | 0.00% | −63,296−11.6% | Reduced |
| Geode Capital Management, LLC | 252,147 | $173.0K | 0.00% | −6,900−2.7% | Reduced |
| Millennium Management LLC | 174,797 | $121.0K | 0.00% | −91,120−34.3% | Reduced |
| Commonwealth Equity Services, LLC | 109,699 | $75.0K | 0.00% | −86−0.1% | Reduced |
| State Street Corp | 97,684 | $67.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 48,132 | $34.0K | 0.00% | −500−1.0% | Reduced |
| Tower Research Capital LLC (TRC) | 41,621 | $29.0K | 0.00% | +14,198+51.8% | Added |
| Group One Trading, L.P. | 40,590 | $28.0K | 0.00% | +32,100+378.1% | Added |
| Prudential Financial Inc | 40,750 | $28.0K | 0.00% | +40,750 | New |
| Two Sigma Investments, LP | 40,871 | $28.0K | 0.00% | +40,871 | New |
| Two Sigma Advisers, LP | 27,200 | $19.0K | 0.00% | +3,500+14.8% | Added |
| Morgan Stanley | 25,486 | $17.0K | 0.00% | −25,732−50.2% | Reduced |
| D. E. Shaw & Co., Inc. | 18,235 | $13.0K | 0.00% | −38,094−67.6% | Reduced |
| Allred Capital Management, LLC | 16,638 | $11.0K | 0.01% | +16,638 | New |
| Hunter Associates Investment Management LLC | 10,880 | $8.00K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 10,414 | $7.00K | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 5,579 | $6.00K | 0.00% | +5,579 | New |
| Federated Hermes, Inc. | 6,711 | $5.00K | 0.00% | +1,078+19.1% | Added |
| Advisor Group Holdings, Inc. | 6,180 | $4.00K | 0.00% | +10.0% | Added |
| UBS Group AG | 6,131 | $4.00K | 0.00% | +6,130+613,000.0% | Added |
| Simplex Trading, LLC | 4,698 | $3.00K | 0.00% | +4,698 | New |
| Wells Fargo & Company | 2,719 | $2.00K | 0.00% | +7+0.3% | Added |
| Bank of America Corp | 1,196 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 476 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Optimum Investment Advisors | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 209 | $0 | 0.00% | 00.0% | Unchanged |
| JJJ Advisors Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 21 | $0 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 8 | $0 | 0.00% | +8 | New |
| Larson Financial Group LLC | 8 | $0 | 0.00% | +8 | New |
| IFP Advisors, Inc | 1,200 | – | – | −1,200−50.0% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,379,936−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −57,380−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −50,146−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −504−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Capital Advisory Group Advisory Services, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |